Urologic Disorders Clinical Trials

3 recruiting

Urologic Disorders Trials at a Glance

9 actively recruiting trials for urologic disorders are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Bethesda, Coral Springs, and Culver City. Lead sponsors running urologic disorders studies include Centre Hospitalier St Anne, Centre Hospitalier de Saint-Denis, and Baylor University.

Browse urologic disorders trials by phase

Treatments under study

About Urologic Disorders Clinical Trials

Looking for clinical trials for Urologic Disorders? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Urologic Disorders trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Urologic Disorders clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

The Neurodevelopmental and Behavioral Phenotyping Screening Protocol

AutismNeurologic DisordersNeurodegenerative Disease+1 more
National Institute of Mental Health (NIMH)5,000 enrolled1 locationNCT00271622
Recruiting

Evaluation and Treatment of Neurosurgical Disorders

Neurologic Disorders
National Institute of Neurological Disorders and Stroke (NINDS)5,000 enrolled1 locationNCT00060541
Recruiting
Not Applicable

Noninvasive Spinal Cord Stimulation for Early SCI

Sexual DysfunctionAutonomic DysfunctionSpinal Cord Injuries+2 more
University of British Columbia60 enrolled1 locationNCT06587841
Recruiting

Reliability and Validity of the PReFS

Traumatic Brain InjuryStrokeSpinal Cord Injury+1 more
Baylor University15 enrolled1 locationNCT07280923
Recruiting
Not Applicable

Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders

Depressive DisorderSchizophreniaNeurologic Disorders+1 more
Centre Hospitalier St Anne600 enrolled3 locationsNCT07295652
Recruiting
Not Applicable

Neurologic Stem Cell Treatment Study

Cognitive ImpairmentDementiaTraumatic Brain Injury+23 more
MD Stem Cells500 enrolled3 locationsNCT02795052
Recruiting

Validation of the Short Form of the "Lower Urinary Tract Symptoms Treatment Constraints Assessment" Questionnaire

Urologic Disorders
Centre Hospitalier de Saint-Denis242 enrolled2 locationsNCT06853366
Recruiting
Phase 1Phase 2

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Sexual DysfunctionAutoimmune DiseasesNeurologic Disorders+8 more
Thomas Advanced Medical LLC5,000 enrolled1 locationNCT04684602
Recruiting
Phase 1

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of Orally Administered PRN2246 in Healthy Volunteers

Immune-mediated neurologic disorders
Clinical Network Services98 enrolled1 locationACTRN12617001457336